Orexigen Therapeutics, Inc.
NASDAQ: OREX
$0.22
-$0.12 (-34.4%)
Closing price April 3, 2018
OREX Articles
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Thursday.Activision Blizzard Inc. (NASDAQ: ATVI) raised to Overweight at...
Published:
Last Updated:
The history of weight loss drugs is sketchy at best. But VIVUS Inc. (NASDAQ: VVUS) is making up on all of its recent losses, after shares slid from almost $30 to just under $26.46 at yesterday’s...
Published:
Last Updated:
The Dow Jones Industrial Average, Nasdaq and S&P 500 are all down more than 1% Thursday morning, with banks and health insurance stocks down the most in the broader market. Nevertheless, the big...
Published:
Last Updated:
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Thursday.Anadarko Petroleum Corporation (NYSE: APC) Raised to Outperform...
Published:
Last Updated:
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) was halted today for news that the company’s weight-loss drug called BELVIQ has been approved. The news is good for all obesity drug makers today. ...
Published:
Last Updated:
We are tracking and analyzing a significant volume spike in shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today. Shares are up nearly 5% at $8.25 and the 12:30 PM trading volume is now over...
Published:
Last Updated:
Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added and deleted from them as money management firms often buy and sell shares,...
Published:
Last Updated:
The major US stock indexes opened significantly lower this morning as investors reacted to the surprise loss of $2 billion by JPMorgan Chase & Co. (NYSE: JPM) disclosed by the bank’s CEO after...
Published:
Last Updated:
VIVUS Inc. (NASDAQ: VVUS) is getting a bit of a haircut this morning on the heels of some news from the Food & Drug Administration which may throw up some caution for its weight loss pill.The FDA has...
Published:
Last Updated:
Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) announced that its application to sell its lorcaserin weight-loss drug in Europe has been accepted by the Europe Medicines Agency. This is the...
Published:
VIVUS, Inc. (NASDAQ: VVUS) is going to likely have a huge day on Thursday. The FDA panel reviewing its Qnexa drug to treat obesity has voted overwhelmingly to offer FDA panel backing in favor of...
Published:
Last Updated:
Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and moves in shares of Adobe Systems Incorporated (NASDAQ: ADBE), Oracle Corporation...
Published:
These are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls.Autodesk, Inc. (NASDAQ: ADSK) Raised to Overweight at...
Published:
Last Updated:
VIVUS, Inc. (NASDAQ: VVUS) is in the news this morning after entering into an agreements with a select group of institutional investors to sell 6,889,098 shares of its common stock. Rather than...
Published:
Last Updated: